---  
layout: startup_page  
title: "Latigo Biotherapeutics"  
id: "latigobio.com"  
permalink: "/latigobiotherapeuticslatigobio.com03172025/"  
website: "https://www.latigobio.com/"  
funding_round: "Series B"  
funding_amount: "$150M"  
investors: "Blue Owl Capital, Deep Track Capital, Access Biotechnology, Qatar Investment Authority, Cormorant Asset Management, Sanofi Ventures, Rock Springs Capital, UPMC Enterprises, Kern Capital, Westlake Village BioPartners, Foresite Capital, 5AM Ventures, Alexandria Venture Investments"  
about: "Latigo Biotherapeutics is a clinical-stage biotechnology company developing innovative non-opioid pain medicines that target the source of pain. Their lead candidate, LTG-001, is an oral, selective Nav1.8 inhibitor for acute pain, and LTG-305 is an oral, selective Nav1.8 inhibitor in Phase 1 clinical trials for chronic pain. Latigo aims to provide effective, rapid-acting pain relief without the risk of addiction."  
markets: "Biotech, Pharmaceuticals, Healthtech"  
hq: "Thousand Oaks, California, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/latigobio/"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/latigo-biotherapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/466121-80"  

date_display: "17-Mar-2025"  
date: "2025-03-17"

# SEO Optimization  
meta_title: "Latigo Biotherapeutics - Series B Funding ($150M)"  
meta_description: "Latigo Biotherapeutics, Latigo Biotherapeutics is a clinical-stage biotechnology company developing innovative non-opioid pain medicines that target the source of pain. Their..."  
meta_keywords: "Latigo Biotherapeutics, Biotech, Pharmaceuticals, Healthtech, Series B funding"  
canonical_url: "https://startup.projectstartups.com/latigobiotherapeuticslatigobio.com03172025/"  
---